Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba in Mild Cognitive and Concentration Impairment
NCT00446485Phase 4Completed
- Sponsor
- Milsing
- Start
- May 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ginkgo biloba extract in Mild Cognitive Impairment (MCI), cerebrovascular insufficiency, sponsored by Milsing. Started May 2007; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
Mild Cognitive Impairment (MCI)cerebrovascular insufficiency
Beyond the preview
Go deeper on NCT00446485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446485.